New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
08:37 EDTCPHDCepheid upgraded at Needham
As previously reported, Needham upgraded Cepheid to Buy from Hold. The firm upgraded shares based on expectations for faster growth driven by recent international launches of HPV and Norovirus, virology expansion, and U.S. sales management changes that should driver faster growth. Price target is $50.
News For CPHD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
10:04 EDTCPHDCepheid issued a long-term Sell rating at Off Wall Street Research
Subscribe for More Information
June 26, 2015
10:00 EDTCPHDOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:05 EDTCPHDCepheid upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum upgraded Cepheid to Buy and raised its price target to $75 from $52. The firm said Cepheid is rapidly expanding its clinical offering and customer reach and is emerging as the leading platform for molecular diagnostics.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use